151 related articles for article (PubMed ID: 31108179)
1. Successful oral desensitization with dasatinib in delayed cutaneous hypersensitivity reactions.
Karaatmaca B; Aytac S; Sahiner UM; Sekerel BE; Soyer O
Ann Allergy Asthma Immunol; 2019 Aug; 123(2):216-217. PubMed ID: 31108179
[No Abstract] [Full Text] [Related]
2. Is dasatinib-related pulmonary hypertension a clinical concern?
Szmit S
Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
[No Abstract] [Full Text] [Related]
3. Desensitization to protein kinase inhibitors: A systematic review.
Chillari KA; Britnell SR; Brown JN; Hammond JM
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):9-15. PubMed ID: 28668246
[No Abstract] [Full Text] [Related]
4. Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib.
Ottmann O; Saglio G; Apperley JF; Arthur C; Bullorsky E; Charbonnier A; Dipersio JF; Kantarjian H; Khoury HJ; Kim DW; Healey D; Strauss L; Cortes JE
Blood Cancer J; 2018 Sep; 8(9):88. PubMed ID: 30190469
[No Abstract] [Full Text] [Related]
5. Rapid desensitization for hypersensitivity reactions to medications.
Castells M
Immunol Allergy Clin North Am; 2009 Aug; 29(3):585-606. PubMed ID: 19563999
[TBL] [Abstract][Full Text] [Related]
6. Delayed Cutaneous Hypersensitivity Reactions to Antibiotics: Management with Desensitization.
McNulty CMG; Park MA
Immunol Allergy Clin North Am; 2017 Nov; 37(4):751-760. PubMed ID: 28965638
[TBL] [Abstract][Full Text] [Related]
7. Successful desensitization procedure to lenalidomide in a patient with delayed hypersensitivity confirmed with a positive LTT.
Lazzarato I; Gonzalez-Muñoz M; Heredia R; Castellar PharmG FR; López de la Guía A; Cabañas R; Fiandor A; Dominguez-Ortega J
Eur Ann Allergy Clin Immunol; 2020 Sep; 52(5):235-237. PubMed ID: 32374557
[No Abstract] [Full Text] [Related]
8. Successful Bendamustine Desensitization for a Delayed-Type Hypersensitivity Reaction.
Martin Garcia C; Sierra Pacho M; Moreno Rodilla E; Callejo Melgosa AM; Martinez Alonso JC; Fernández Colino T; Acevedo Del Barrio G; Gil Valiño C; Eiris Aradas MC
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):68-69. PubMed ID: 30785109
[No Abstract] [Full Text] [Related]
9. Unsuccessful Desensitization in a Child with Hypersensitivity to Diazoxide.
Mori F; Sarti L; Barni S; Lodi L; Federico G; Novembre E
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):457-459. PubMed ID: 29149786
[TBL] [Abstract][Full Text] [Related]
10. Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia.
Khoury HJ; Goldberg SL; Mauro MJ; Stone RM; Deininger MW; Bradley-Garelik MB; Mohamed H; Guilhot F
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):341-349.e1. PubMed ID: 27133948
[TBL] [Abstract][Full Text] [Related]
11. Successful Desensitization to Oxaliplatin After a Single Initial Dose of Omalizumab in a Patient With Elevated IgE Levels.
Penella J; Quan P; Carvallo A; Chopitea A; Sala P; García Del Barrio MA; Gastaminza G; Goikoetxea MJ
J Investig Allergol Clin Immunol; 2020; 30(4):293-295. PubMed ID: 32101174
[No Abstract] [Full Text] [Related]
12. Delayed hypersensitivity skin reaction to hydroxychloroquine: Successful short desensitization.
Barailler H; Milpied B; Chauvel A; Claraz P; Taïeb A; Seneschal J; Darrigade AS
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):307-308. PubMed ID: 29800755
[No Abstract] [Full Text] [Related]
13. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.
Kostos L; Burbury K; Srivastava G; Prince HM
Platelets; 2015; 26(8):809-11. PubMed ID: 26029798
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation.
Ito Y; Miyamoto T; Kamimura T; Aoki K; Henzan H; Aoki T; Shiratsuchi M; Kato K; Nagafuji K; Ogawa R; Eto T; Iwasaki H; Akashi K
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e47-54. PubMed ID: 25445469
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Brattås MK; Reikvam H; Tvedt THA; Bruserud Ø
Expert Opin Investig Drugs; 2019 May; 28(5):411-420. PubMed ID: 30916583
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
McGrath K; Stein B; Kalhagen L; Leighton L
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
[No Abstract] [Full Text] [Related]
17. Dasatinib-induced loss of eyebrows.
Naithani R
Br J Haematol; 2017 Nov; 179(3):362. PubMed ID: 28737227
[No Abstract] [Full Text] [Related]
18. Dasatinib-induced nephrotic syndrome.
Hirano T; Hashimoto M; Korogi Y; Tsuji T; Miyanaka K; Yamasaki H; Tsuda H
Leuk Lymphoma; 2016; 57(3):726-7. PubMed ID: 26436329
[No Abstract] [Full Text] [Related]
19. Tyrosine Kinase Inhibitor-associated Fibrothorax.
Adrianza AM; Jimenez CA; Aldana GL; Pozo L; Cortes JE; Sagar AES
Am J Respir Crit Care Med; 2019 Jun; 199(11):1432. PubMed ID: 30785770
[No Abstract] [Full Text] [Related]
20. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP
Cancer; 2016 May; 122(9):1398-407. PubMed ID: 26998677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
